With that in mind, let's consider two stocks that haven't performed well recently and are now near their 52-week lows but ...

CRISPR stock decline is influenced by Editas Medicine's struggles, but CRSP remains strong with FDA approval and strategic ...

What's going on with CRISPR Therapeutics ( CRSP -0.99%)? The company's shares have been southbound for the better part of three years. And despite major regulatory wins since late 2023, the biotech ...

We recently compiled a list of the 10 Best Gene Therapy Stocks to Buy Right Now. In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against the other ...

We recently compiled a list of the 10 Best Gene Therapy Stocks to Buy Right Now. In this article, we are going to take a look ...

Dennison also describes how CRISPR screening tools will be key to further ... I think the reason is that the clinical team is relatively small, so they can buy into the project. We've got good links ...